Literature DB >> 20659973

Functional full-term placentas formed from parthenogenetic embryos using serial nuclear transfer.

Takafusa Hikichi1, Hiroshi Ohta, Sayaka Wakayama, Teruhiko Wakayama.   

Abstract

Mammalian parthenogenetic embryos invariably die in mid-gestation from imprinted gene defects and placental hypoplasia. Based on chimera experiments, trophoblastic proliferation is supposed to be inhibited in the absence of a male genome. Here, we show that parthenogenetic mouse embryonic cell nuclei can be reprogrammed by serial rounds of nuclear transfer without using any genetic modification. The durations of survival in uteri of cloned foetuses derived from green fluorescent protein (GFP)-labelled parthenogenetic cell nuclei were extended with repeated nuclear transfers. After five repeats, live cloned foetuses were obtained up to day 14.5 of gestation; however, they did not survive longer even when we repeated nuclear transfer up to nine times. All foetuses showed intestinal herniation and possessed well-expanded large placentas. When embryonic stem (ES) cells derived from fertilised embryos were aggregated with the cloned embryos, full-term offspring with large placentas were obtained from the chimeric embryos. Those placentas were derived from parthenogenetic cell nuclei, judging from GFP expression. The patterns of imprinted gene expression and methylation status were similar to their parthenogenetic origin, except for Peg10, which showed the same level as in the normal placenta. These results suggest that there is a limitation for foetal development in the ability to reprogramme imprinted genes by repeated rounds of nuclear transfer. However, the placentas of parthenogenetic embryos can escape epigenetic regulation when developed using nuclear transfer techniques and can support foetal development to full gestation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20659973     DOI: 10.1242/dev.051375

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  3 in total

1.  Downregulation of H19 improves the differentiation potential of mouse parthenogenetic embryonic stem cells.

Authors:  Neli P Ragina; Karianne Schlosser; Jason G Knott; Patricia K Senagore; Pamela J Swiatek; Eun Ah Chang; Walid D Fakhouri; Brian C Schutte; Matti Kiupel; Jose B Cibelli
Journal:  Stem Cells Dev       Date:  2011-09-14       Impact factor: 3.272

2.  Ascorbic acid improves pluripotency of human parthenogenetic embryonic stem cells through modifying imprinted gene expression in the Dlk1-Dio3 region.

Authors:  Yang Yu; Qian Gao; Hong-cui Zhao; Rong Li; Jiang-man Gao; Ting Ding; Si-yu Bao; Yue Zhao; Xiao-fang Sun; Yong Fan; Jie Qiao
Journal:  Stem Cell Res Ther       Date:  2015-04-14       Impact factor: 6.832

3.  Production of mouse offspring from inactivated spermatozoa using horse PLCζ mRNA.

Authors:  Yunosuke Yamamoto; Naoki Hirose; Satoshi Kamimura; Sayaka Wakayama; Junya Ito; Masatoshi Ooga; Teruhiko Wakayama
Journal:  J Reprod Dev       Date:  2019-12-18       Impact factor: 2.214

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.